Pharmacological evaluation of novel 5-HT 3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery by Deepali Gupta, Mahesh Radhakrishnan, Devadoss Thangaraj, Yeshwant Kurhe

Connect to this object online.

"A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes" by Deepali Gupta, Sean B. Ogden, Kripa Shankar, Salil Varshney, Jeffrey M. Zigman

Connect to this object online.

Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions by Deepali Gupta, Anna M. Patterson, Sherri Osborne-Lawrence, Angie L. Bookout, Salil Varshney, Kripa Shankar, Omprakash Singh, Nathan P. Metzger, Corine P. Richard, Steven C. Wyler, Joel K. Elmquist, Jeffrey M. Zigman

Connect to this object online.

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue by Kripa Shankar, Nathan P. Metzger, Omprakash Singh, Bharath K. Mani, Sherri Osborne-Lawrence, Salil Varshney, Deepali Gupta, Sean B. Ogden, Shota Takemi, Corine P. Richard, Karabi Nandy, Chen Liu, Jeffrey M. Zigman

Connect to this object online.

A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice by Kripa Shankar, Nathan P. Metzger, Connor Lawrence, Deepali Gupta, Sherri Osborne-Lawrence, Salil Varshney, Omprakash Singh, Corine P. Richard, Alexander N. Zaykov, Rebecca Rolfts, Barent N. DuBois, Diego Perez-Tilve, Bharath K. Mani, Suntrea T.G. Hammer, Jeffrey M. Zigman

Connect to this object online.